Litcius/Paper detail

Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments

Yasuhiro Shirakawa, Hiroshi Tazawa, Shunsuke Tanabe, Nobuhiko Kanaya, Kazuhiro Noma, Takeshi Koujima, Hajime Kashima, Takuya Kato, Shinji Kuroda, Satoru Kikuchi, Shunsuke Kagawa, Kuniaki Katsui, Susumu Kanazawa, Yasuo Urata, Toshiyoshi Fujiwara

2021European Journal of Cancer67 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRadiation therapyCancerBiopsyGastroenterologyInternal medicineOncologyVirus-based gene therapy researchTelomeres, Telomerase, and SenescenceRNA Interference and Gene Delivery
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments | Litcius